Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Hormones & Cancer|August 16, 2014
Elevated APOBEC3B correlates with poor outcomes for estrogen-receptor-positive breast cancersAnieta M Sieuwerts, Scooter Willis, Michael B Burns, et al.
Breast Cancer Research and Treatment|July 17, 2008
Downregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancerMaurice P H M Jansen, Kirsten Ruigrok-Ritstier, Lambert C J Dorssers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancerEls M J J Berns, Jan G M Klijn, Maxime P Look, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profilingMaurice P H M Jansen, John A Foekens, Iris L van Staveren, et al.
American Journal of Cancer Research|May 18, 2016
SIAH2 protein expression in breast cancer is inversely related with ER status and outcome to tamoxifen therapyKimberly D van der Willik, Mieke M Timmermans, Carolien Hm van Deurzen, et al.
Breast Cancer Research and Treatment|April 18, 2013
Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifenDiana E Ramirez-Ardila, Jean C Helmijr, Maxime P Look, et al.
Oncotarget|December 15, 2015
Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancerTommaso De Marchi, Anne M Timmermans, Marcel Smid, et al.
Oncotarget|October 1, 2013
CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlationsRoxana S Redis, Anieta M Sieuwerts, Maxime P Look, et al.
Molecular Oncology|August 20, 2015
4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancerTommaso De Marchi, Ning Qing Liu, Cristoph Stingl, et al.
Scientific Reports|August 26, 2016
Prognostic significance of nuclear expression of UMP-CMP kinase in triple negative breast cancer patientsNing Qing Liu, Tommaso De Marchi, Annemieke Timmermans, et al.
Pageof 6